Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Oncothyreon in $15M private placement; stock dives
bizjournals.com
Saturday, September 25, 2010 - 12:01pm
tags:
Oncothyreon, investors
Why the EU banned Avandia but the FDA didn't
CNN/Fortune
Friday, September 24, 2010 - 12:47pm
tags:
Europe, Avandia, FDA, GSK, diabetes
Novartis Hid Health Risks of Bone Drugs, Lawyer Tells Jury in New Jersey
Bloomberg
Friday, September 24, 2010 - 11:44am
tags:
Novartis, Zometa, Aredia
You Can Blame Bristol-Myers’ Layoffs on Failed Launch of Me-Too Diabetes Drug
BNET Pharma
Friday, September 24, 2010 - 11:42am
tags:
layoffs, Bristol-Myers Squibb, Onglyza, diabetes, blood thinners, Plavix
Biotech’s Revolving Door
Forbes
Friday, September 24, 2010 - 11:40am
tags:
biotech, Advaxis
Novartis deal over, Alnylam cuts staff
Bizjournals.com
Friday, September 24, 2010 - 11:16am
tags:
Novartis, Alnylam, layoffs, RNAi
Amgen recalls anemia drugs due to glass flakes
Yahoo/AP
Friday, September 24, 2010 - 11:14am
tags:
Amgen, anemia, recalls, Epogen, Procrit
[video] They Just Don't Get Glaxo!
TheStreet.com
Friday, September 24, 2010 - 11:13am
tags:
GSK, Avandia, media coverage
The Novo Nordisk: Hottest Big Pharma You Never Heard Of
Forbes
Friday, September 24, 2010 - 11:12am
tags:
Novo Nordisk, insulin, diabetes
The Rapid Growth Of Layoffs In Pharma, As Industry Despairs Of Its Future
247WallSt
Friday, September 24, 2010 - 11:09am
tags:
Wyeth, Schering Plough, Pfizer, Merck, layoffs, Bristol-Myers Squibb, Abbott Laboratories
Avandia: Lessons Learned & Unanswered Questions
Pharmalot
Friday, September 24, 2010 - 10:11am
tags:
Avandia, GSK, diabetes
AstraZeneca Wins EU Approval for Blood Thinner to Rival World's No. 2 Drug
Bloomberg
Friday, September 24, 2010 - 10:03am
tags:
AstraZeneca, blood thinners, Europe, Plavix, Brilique, Brilinta
Similac Recall and Response - Consumer Outrage
TheStreet.com
Friday, September 24, 2010 - 10:01am
tags:
Abbott Laboratories, recalls, infant formula, Similac
Novartis to Sell U.S. Rights to Enablex
TheStreet.com
Friday, September 24, 2010 - 9:58am
tags:
Novartis, Enablex, Warner Chilcott, overactive bladder
Merck KGaA drops 10 per cent after drug rejection
FT.com
Friday, September 24, 2010 - 9:57am
tags:
Merck KGaA, MS, multiple sclerosis
Gilenya: A Blockbuster in Due Time
Motley Fool
Friday, September 24, 2010 - 9:55am
tags:
Gilenya, MS, multiple sclerosis, Novartis
Drugmaker Bristol-Myers Squibb is streamlining, will cut 840 jobs worldwide in next 6 months
Yahoo/AP
Thursday, September 23, 2010 - 5:35pm
tags:
layoffs, reorganization, Bristol-Myers Squibb
Regulators pull plug on Glaxo diabetes drug: Europe orders marketing halt, U.S. orders restrictions
Marketwatch
Thursday, September 23, 2010 - 2:57pm
tags:
GSK, Europe, FDA, diabetes, Avandia, Avaglim, Avandamet
Reata-Abbott deal may be worth $800M-plus
Bizjournals.com
Thursday, September 23, 2010 - 2:55pm
tags:
Abbott Laboratories, Reata, drug development
Big Pharma's Challenge: Figuring out China
CNN/Fortune
Thursday, September 23, 2010 - 2:52pm
tags:
China, Big Pharma, Pfizer, GSK, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.